Latest Psoriatic arthritis Stories
Arthritis is a very painful inflammation of one or more of a person’s joints. To better understand the condition, it is important to understand the common types that are regularly diagnosed.
NORWALK, Conn., July 31, 2014 /PRNewswire/ -- UBM Medica US announces that Rheumatology Network,
Nearly half a million dollars given to early-career physicians to study psoriatic disease PORTLAND, Ore., July 17, 2014 /PRNewswire-USNewswire/ -- Twelve residents and medical students each
PORTLAND, Ore., July 16, 2014 /PRNewswire-USNewswire/ -- Thirteen scientists received a total of $1.05 million in funding from the National Psoriasis Foundation for projects that aim to identify new
Psoriasis Foundation will drive efforts to cure psoriatic disease, help those affected PORTLAND, Ore., July 9, 2014 /PRNewswire-USNewswire/ -- National Psoriasis Foundation will double the
Data presented today at the European League Against Rheumatism Annual Congress (EULAR 2014) showed that a significant number of patients with psoriatic arthritis (PsA) were not receiving doses of the tumour necrosis factor-alpha (TNFα) inhibitor adalimumab necessary to achieve optimal clinical benefit.
- Dermira obtains exclusive rights to develop Cimzia® in psoriasis in the US, Canada and the European Union BRUSSELS and REDWOOD CITY, Calif., July 3, 2014 /PRNewswire/ -- UCB, a global biopharmaceutical
Patient advocacy group teams with The Dermatologist to educate healthcare providers on the specifics of psoriasis research and treatment. Malvern, PA (PRWEB)
NPF Psoriatic Arthritis Project to improve diagnosis, care and treatment for millions PORTLAND, Ore., June 26, 2014 /PRNewswire-USNewswire/ -- Millions of Americans with psoriatic arthritis--a
~Expert panel shares tips, encouraging patients to take a 360° approach to managing their disease and to not give up until they're satisfied~
- Small missiles, especially grape, canister, fragments of iron, and the like, when fired, as upon an enemy at close quarters.
- To fire mitraille at.